Diffusing capacity for carbon monoxide (DLCO) change and outcome in advanced non-small cell lung cancer (aNSCLC) treated with immune checkpoint inhibitors (ICIs).


Por: Montes A, Sanchez A, Rondán M, Cases S, Soler J, Tena I, Navarro B, Timacheva D, Modesto M, Lorente D

Publicada: 1 jun 2025
Resumen:

ISSN: 0732183X





Journal Of Clinical Oncology
Editorial
AMER SOC CLINICAL ONCOLOGY, 2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA, Estados Unidos America
Tipo de documento: Article
Volumen: 43 Número: 16_SUPPL
Páginas: 20602-20602
WOS Id: 001690307100003

MÉTRICAS